
Cefryth 1000mg/500mg Injection
Marketer
Penryth Labs Private Limited
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Cefryth 1000mg/500mg Injection
Cefryth 1000mg/500mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administered solely under medical guidance, this medication requires adherence to the prescribed schedule. Complete the full treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability is usually unaffected, avoid driving if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration promote recovery. Your doctor may order tests to monitor the drug's effects.
Primary Ingredients of Cefryth 1000mg/500mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Cefryth 1000mg/500mg Injection
Managing bacterial illnesses
Major Benefits of Cefryth 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefryth 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Cefryth 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cefryth 1000mg/500mg Injection works:
Cefryth 1000mg/500mg Injection unites Cefoperazone, a bacterial growth inhibitor, and Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam complements this by countering bacterial resistance mechanisms, thereby bolstering Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Cefryth 1000mg/500mg Injection and alcohol can trigger adverse reactions, including facial flushing, tachycardia, nausea, thirst, chest discomfort, and hypotension (a Disulfiram-like effect).
PregnancySAFE IF PRESCRIBED
Cefryth 1000mg/500mg injections are typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human clinical trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Cefryth 1000mg/500mg injections are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
Cefryth 1000mg/500mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data on Cefryth 1000mg/500mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefryth 1000mg/500mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Cefryth 1000mg/500mg Injection :
Should you inadvertently omit a scheduled dose of Cefryth 1000mg/500mg Injection, seek immediate medical advice.
Facts to Know About Cefryth 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
